Navigation Links
A new breast cancer susceptibility gene
Date:3/29/2012

SALT LAKE CITY -- Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.

Sean Tavtigian, Ph.D., a Huntsman Cancer Institute (HCI) investigator and associate professor in the Department of Oncological Sciences at the University of Utah (U of U) is one of three co-principal investigators on the study, along with David Goldgar, Ph.D., professor in the Department of Dermatology at the U of U and an HCI investigator, and Melissa Southey, Ph.D., professor in the Department of Pathology at the University of Melbourne, Australia.

"We have added to the list of genes that harbour mutations causing breast cancer," said Tavtigian. "This knowledge will improve breast cancer diagnostics and add years to patients' lives. More important, relatives who have not been affected by the disease but carry the mutations will benefit even more. They can find out they are at risk before they have cancer and take action to reduce their risk or catch the cancer early."

XRCC2 may also provide a new target for chemotherapy. "A type of drug called a PARP inhibitor appears to kill tumor cells that have gene mutations in a particular DNA repair pathway. XRCC2 is in this pathway, as are BRCA1 and BRCA2. It's reasonably likely that a breast cancer patient who has a mutation in XRCC2 will respond well to treatment with PARP inhibitors," said Tavtigian.

According to Tavtigian, many breast cancer cases appear in families with a weak history of the disease. Only about 30 percent of the familial risk for breast cancer can be explained by a combination of mutations to and common sequence variation in the known breast cancer susceptibility genes. "So far most of the clinical diagnostic effort has been directed toward t
'/>"/>

Contact: Linda Aagard
801-587-7639
University of Utah Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Breast cancer risk gene discovery fast tracked by new technology
2. Protein jailbreak helps breast cancer cells live
3. Study details on-off switch that promotes or suppresses breast cancer
4. Breast cancer spread triggered by a cleaver-wielding protein on cancer cells surface
5. Some breast cancer spread may be triggered by a protein, study shows
6. Researchers identify possible receptor for key breast cancer regulator
7. ISG15: A novel therapeutic target to slow breast cancer cell motility
8. Cell-CT: A new dimension in breast cancer research
9. Breastfeeding promotes healthy growth
10. Breastfeeding saved babies in 19th century Montreal
11. MRI may be noninvasive method to measure breast cancer prognosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... , December 9, 2014 ... ITN,s BCARD Platform   ... enterprise meeting scheduling solutions for business-to-business (B2B) events, ... world leader in mobile near-field communication (NFC), Bluetooth ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a ... $2.3 million in Series A1 funding led by UK-based ... also participated in the investment round. "We ... healthcare community adopts next-generation sequencing and seeks new approaches ... Reid Robison , MD MBA, and CEO of ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Bees among agriculture,s hardest workers as key pollinators ... declined over the last half-century, with die-offs in recent ... a $1.5 million National Science Foundation (NSF) multi-institutional grant ... consolidate data from 10 natural history bee collections across ...
... An Australian scientist has discovered what could be the world,s ... unique Pacific elkhorn coral was found while conducting underwater surveys ... Dr Zoe Richards of the ARC Centre of Excellence for ... physical resemblance to the critically endangered and fast-vanishing elkhorn coral ...
... Energy,s (DOE) Argonne National Laboratory will lead projects that ... time at Argonne,s Leadership Computing Facility (ALCF). The ALCF ... capable of performing 557 trillion calculations per second, enabling ... or months rather than years. "By providing millions ...
Cached Biology News:New $1.5 million NSF grant to track bee declines and pollination 2Super-rare 'elkhorn' coral found in Pacific 2Super-rare 'elkhorn' coral found in Pacific 3Supercomputers take science by storm 2Supercomputers take science by storm 3
(Date:12/13/2014)... 13, 2014 CanDiag, Inc., a University ... has changed its name to OncoTab, Inc. , ... where we are today,” said CEO and Chief Science ... applications beyond breast cancer diagnostics to include imaging and ... that evolution.” , Founded in 2011 by Dr. Mukherjee, ...
(Date:12/13/2014)... BELLLINGHAM, Washington, USA, and TAICHUNG, Taiwan (PRWEB) December 12, ... to rise, despite less rosy indicators in overall global ... international society for optics and photonics , said in ... the International Conference) on 5 December at the National ... cited solar energy, which is being integrated into future ...
(Date:12/13/2014)... Dec. 12, 2014  Vermillion, Inc. (NasdaqCM: VRML), a bio-analytical ... appointments of Veronica G. H. Jordan , Ph.D., ... Board of Directors, bringing the total number of directors ... Jim LaFrance , Chairman, President, and Chief ... to announce the appointments of Veronica and David to ...
(Date:12/12/2014)... InSphero AG, the world’s leading provider of 3D ... data presented recently by Genentech (South San Francisco, CA) ... model system for assessment of liver toxicity. ... Analysis and Screening Technologies (FAST) Congress summarized a ... 3D InSight™ Human Liver Microtissues to 42 known ...
Breaking Biology Technology:CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 3Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 5Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... Switzerland, February 11 ,Acrongenomics, Inc. (OTCBB:AGNM), the Geneva ... and The Imperial Venture Fund a,time line for ... acquisition of 10.9% of the shares of Molecular ... agreed by all parties that the full,acquisition of ...
... Calif., Feb. 8 Anesiva,Inc. (Nasdaq: ANSV ) ... company,s board of directors. Mr. Janney previously served on ... transitioned off,the board following the merger of Anesiva and ... the Anesiva board of directors,and we are very pleased ...
... Medical today issued the,following response to a press release ... GmbH had achieved in the AIPPI in,AGA,s patent dispute ... sort was conducted before the AIPPI and that,organization agreed ... AGA has not been involved in any proceedings with ...
Cached Biology Technology:Acrongenomics on Track to Acquire Molecular Vision 2Acrongenomics on Track to Acquire Molecular Vision 3Acrongenomics on Track to Acquire Molecular Vision 4Anesiva Appoints Daniel Janney to Board of Directors 2Anesiva Appoints Daniel Janney to Board of Directors 3AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe 2
... degrades single-stranded DNA and RNA endonucleolytically ... acids (DNA:DNA, DNA:RNA or RNA:RNA) are ... high concentrations of enzyme (1). The ... termini from double-stranded DNA (2), for ...
... catalyzes the transfer of the ... 5-terminus of polynucleotides or to ... The enzyme, purified from recombinant ... to phosphorylate RNA, DNA and ...
... verticillus USBio Analyzed PRODUCT SPECIFICATIONS Form: White powder Assay: 1.5 ... units/ml): 4.5 to 6.0 Loss On Drying: less than or ... 0.1% Bleomycin Content: A 2 : 55 - 70% B ... : greater than or equal to 90% B 4 : ...
A powerful, easy-to-use solution, the SORVALL RC12BP Blood Processing System allows you to manufacture blood components quickly and cost-effectively while ensuring product quality, safety, and GMP co...
Biology Products: